By thoroughly analyzing the biological functions of c-Met and its role in the progression of pancreatic cancer, this study not only validates the efficacy of CAR macrophage therapy targeting c-Met but also solidifies c-Met’s position as a therapeutic target. The gene discussed is MET; the disease is pancreatic neoplasm.